In the dynamic world of pharmaceutical manufacturing, staying ahead means continually refining and upgrading the mechanisms that drive production forward. Minaris Regenerative Medicine GmbH has positioned itself at the forefront of this advancement by implementing the latest digital Manufacturing
Pharma Industry Poised to Transform ESG Reporting with New EU Directive The pharmaceutical industry is on the brink of a significant transformation in how it communicates its sustainability efforts, driven by the impending Environmental, Social, and Governance (ESG) regulations set to take effect
The pharmaceutical industry is undergoing a significant transformation, driven by global events and technological advancements. As companies navigate this evolving landscape, they are focusing on remote work, diversity, equity, and inclusion (DE&I), and the integration of artificial intelligence
The pharmaceutical industry is witnessing a significant shift towards domestic manufacturing in the United States. This trend, driven by government incentives, the need for supply chain resilience, and strategic efforts to reduce dependency on international manufacturing, is poised to have
McGuff Pharmaceuticals, Inc. (MPI) recently achieved a significant milestone by securing FDA approval for its cutting-edge, 86,000-square-foot sterile fill-and-finish cGMP manufacturing facility in Santa Ana, CA. This landmark event is set to unlock considerable business opportunities within the
In recent years, cell therapy has emerged as one of the most promising frontiers in modern medicine, revolutionizing the treatment landscape for a variety of chronic and debilitating diseases such as cancer and autoimmune disorders. Researchers and biotech companies have been exploring innovative
